文献速递中医内科中药与中成药合理使用

中药治疗缺血性心脏病的治疗性血管新生:综述

Therapeutic Angiogenesis of Chinese Herbal Medicines in Ischemic Heart Disease: A Review.
PubMed 文献 · Front Pharmacol · 2018-04-26

该综述总结中药在缺血性心脏病中促进治疗性血管新生的研究进展与潜在机制,并概述其局限性与挑战。

要点

  • 中药可通过靶向血管新生对缺血性心脏病发挥治疗作用。
  • 治疗性血管新生对无法行血管成形术或搭桥术的患者尤为重要。
  • 中药在缺血性心脏病促血管新生的机制是中医领域重要课题。

核心结论

  • 中药可通过靶向血管新生对缺血性心脏病发挥治疗作用,但存在局限性与挑战。

研究设计与样本

  • 综述总结中药在缺血性心脏病中促血管新生的研究进展与潜在机制。

主要发现

  • 动物模型证据增多,显示中药可靶向血管新生对缺血性心脏病产生治疗效应。
  • 治疗性血管新生通过促进缺血心肌血流灌注改善心功能。
  • 该治疗对无法接受血管成形术或搭桥术的患者尤为重要。

临床怎么用

  • 关注中药作为缺血性心脏病治疗性血管新生策略的潜在价值。
  • 重视无法行血管成形术或搭桥术患者的治疗性血管新生需求。

局限性

  • 综述概述了中药的局限性及其面临的挑战。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Ischemic heart disease (IHD) is one of the primary causes of death around the world. Therapeutic angiogenesis is a promising innovative approach for treating IHD, improving cardiac function by promoting blood perfusion to the ischemic myocardium. This treatment is especially important for targeting patients that are unable to undergo angioplasty or bypass surgery. Chinese herbal medicines have been used for more than 2,500 years and they play an important role alongside contemporary medicines in China. Growing evidence in animal models show Chinese herbal medicines can provide therapeutic effect on IHD by targeting angiogenesis. Identifying the mechanism in which Chinese herbal medicines can promote angiogenesis in IHD is a major topic in the field of traditional Chinese medicine, and has the potential for advancing therapeutic treatment. This review summarizes the progression of research and highlights potential pro-angiogenic mechanisms of Chinese herbal medicines in IHD. In addition, an outline of the limitations of Chinese herbal medicines and challenges they face will be presented.

来源:Front Pharmacol,查看原文。版权归原作者所有。

引用

  1. Guo D, Murdoch CE, Liu T, et al. Therapeutic Angiogenesis of Chinese Herbal Medicines in Ischemic Heart Disease: A Review. Front Pharmacol. 2018. PMID: 29755358. doi:10.3389/fphar.2018.00428

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。